200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 1530-03-6

1530-03-6

1530-03-6 | 1,1-DIPHENYLPROPANE

CAS No: 1530-03-6 Catalog No: AG003D95 MDL No:

Product Description

Catalog Number:
AG003D95
Chemical Name:
1,1-DIPHENYLPROPANE
CAS Number:
1530-03-6
IUPAC Name:
1-phenylpropylbenzene
InChI:
InChI=1S/C15H16/c1-2-15(13-9-5-3-6-10-13)14-11-7-4-8-12-14/h3-12,15H,2H2,1H3
InChI Key:
BUZMJVBOGDBMGI-UHFFFAOYSA-N

Properties

Complexity:
143  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
196.125g/mol
Formal Charge:
0
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
0
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
196.293g/mol
Monoisotopic Mass:
196.125g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
0A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.1  

Literature

Title Journal
Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Bioorganic & medicinal chemistry letters 20120215
N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study. Naunyn-Schmiedeberg's archives of pharmacology 20110901
Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study. Bioorganic & medicinal chemistry 20101115
Self-assembly of bis(merocyanine) tweezers into discrete bimolecular pi-stacks. Chemistry (Weinheim an der Bergstrasse, Germany) 20090101
[Development of novel nuclear receptor ligands based on receptor-folding inhibition hypothesis]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070201
Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology. Journal of medicinal chemistry 20060223
Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives. Bioorganic & medicinal chemistry letters 20041101
Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists. European journal of medicinal chemistry 20030401
Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. Journal of medicinal chemistry 20020606

Related Products

© 2019 Angene International Limited. All rights Reserved.